Terms: = Breast cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
3678 results:
1. In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques.
Gondokesumo ME; Rasyak MR
Breast Dis; 2024; 43(1):99-110. PubMed ID: 38758988
[TBL] [Abstract] [Full Text] [Related]
2. D-arabinose induces cell cycle arrest by promoting autophagy via p38 MAPK signaling pathway in breast cancer.
Tang Z; Song H; Qin S; Tian Z; Zhang C; Zhou Y; Cai R; Zhu Y
Sci Rep; 2024 May; 14(1):11219. PubMed ID: 38755221
[TBL] [Abstract] [Full Text] [Related]
3. The Human Intermediate Prolactin Receptor I-tail Contributes breast Oncogenesis by Targeting Ras/MAPK Pathway.
Shen S; Radhakrishnan SK; Harrell JC; Puchalapalli M; Koblinski J; Clevenger C
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38713636
[TBL] [Abstract] [Full Text] [Related]
4. Activation of the MEK/erk Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
5. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract] [Full Text] [Related]
6. Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in breast cancer.
Wang R; Khatpe AS; Kumar B; Mang HE; Batic K; Adebayo AK; Nakshatri H
Cancer Res Commun; 2024 May; 4(5):1282-1295. PubMed ID: 38651826
[TBL] [Abstract] [Full Text] [Related]
7. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent erk1/2 Inhibitors.
Shuai W; Xiao H; Yang P; Zhang Y; Bu F; Wu Y; Sun Q; Wang G; Ouyang L
J Med Chem; 2024 Apr; 67(8):6425-6455. PubMed ID: 38613499
[TBL] [Abstract] [Full Text] [Related]
8. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative breast cancer.
Tang C; Jiang ST; Li CX; Jia XF; Yang WL
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
[TBL] [Abstract] [Full Text] [Related]
9. TIM3 activates the erk1/2 pathway to promote invasion and migration of thyroid tumors.
Jin X; Yin Z; Li X; Guo H; Wang B; Zhang S; Li Y
PLoS One; 2024; 19(4):e0297695. PubMed ID: 38568917
[TBL] [Abstract] [Full Text] [Related]
10. Parabens promotes invasive properties of multiple human cells: A potential cancer-associated adverse outcome pathway.
Wang L; Chen L; Schlenk D; Li F; Liu J
Sci Total Environ; 2024 May; 926():172015. PubMed ID: 38547973
[TBL] [Abstract] [Full Text] [Related]
11. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target.
Li Y; Yang W; Liu C; Zhou S; Liu X; Zhang T; Wu L; Li X; Zhang J; Chang E
Int Immunopharmacol; 2024 May; 132():111918. PubMed ID: 38537539
[TBL] [Abstract] [Full Text] [Related]
12. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
Cerutti C; Lucotti S; Menendez ST; Reymond N; Garg R; Romero IA; Muschel R; Ridley AJ
Cell Rep; 2024 Apr; 43(4):113989. PubMed ID: 38536816
[TBL] [Abstract] [Full Text] [Related]
13. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.
Priyanka HP; Pratap UP; Nair RS; Vasantharekha R; ThyagaRajan S
Med Oncol; 2024 Mar; 41(5):92. PubMed ID: 38526769
[TBL] [Abstract] [Full Text] [Related]
14. Discovery of the tryptanthrin-derived indoloquinazoline as an anti-breast cancer agent via erk/JNK activation.
Chang CS; Bai LY; Chiu CF; Hu JL; Weng JR
Environ Toxicol; 2024 Jun; 39(6):3710-3720. PubMed ID: 38511855
[TBL] [Abstract] [Full Text] [Related]
15. E-cadherin interacts with EGFR resulting in hyper-activation of erk in multiple models of breast cancer.
Russo GC; Crawford AJ; Clark D; Cui J; Carney R; Karl MN; Su B; Starich B; Lih TS; Kamat P; Zhang Q; Nair PR; Wu PH; Lee MH; Leong HS; Zhang H; Rebecca VW; Wirtz D
Oncogene; 2024 May; 43(19):1445-1462. PubMed ID: 38509231
[TBL] [Abstract] [Full Text] [Related]
16. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.
Li Z; Liu Q; Cai Y; Ye N; He Z; Yao Y; Ding Y; Wang P; Qi C; Zheng L; Wang L; Zhou J; Zhang QQ
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167114. PubMed ID: 38447883
[TBL] [Abstract] [Full Text] [Related]
17. Altered hormone expression induced genetic changes leads to breast cancer.
Thakur A; Rana N; Kumar R
Curr Opin Oncol; 2024 Mar; 36(2):115-122. PubMed ID: 38441060
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of tyrosine kinase inhibitors examined by a combination of Raman micro-spectroscopy and a deep wavelet scattering-based multivariate analysis framework.
Schuler I; Schuler M; Frick T; Jimenez D; Maghnouj A; Hahn S; Zewail R; Gerwert K; El-Mashtoly SF
Analyst; 2024 Mar; 149(7):2004-2015. PubMed ID: 38426854
[TBL] [Abstract] [Full Text] [Related]
19. Phloretin Inhibits the Proliferation of breast cancer Cells Through the Down-regulation of Estrogen Receptor α.
Jang SY; Kim J; Hong E; Yang YJ; Na Y; Yeom CH; Park S
Anticancer Res; 2024 Mar; 44(3):1109-1120. PubMed ID: 38423666
[TBL] [Abstract] [Full Text] [Related]
20. The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.
Pandithar S; Galke D; Akume A; Belyakov A; Lomonaco D; Guerra AA; Park J; Reff O; Jin K
Mol Biol Rep; 2024 Feb; 51(1):331. PubMed ID: 38393465
[TBL] [Abstract] [Full Text] [Related]
[Next]
